Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 C-4 modified sialosides enhance binding to Siglec-2 (CD22): towards potent Siglec inhibitors for immunoglycotherapy.

× No keyword cloud information.

14 in total

Review 1. The role of CD22 and Siglec-G in B-cell tolerance and autoimmune disease.

Authors: Jennifer Müller; Lars Nitschke
Journal: Nat Rev Rheumatol Date: 2014-04-29 Impact factor: 20.543

2. Disubstituted Sialic Acid Ligands Targeting Siglecs CD33 and CD22 Associated with Myeloid Leukaemias and B Cell Lymphomas.

Authors: Cory D Rillahan; Matthew S Macauley; Erik Schwartz; Yuan He; Ryan McBride; Britni M Arlian; Janani Rangarajan; Valery V Fokin; James C Paulson
Journal: Chem Sci Date: 2014-06-01 Impact factor: 9.825

Review 3. Therapeutic Targeting of Siglecs using Antibody- and Glycan-Based Approaches.

Authors: Takashi Angata; Corwin M Nycholat; Matthew S Macauley
Journal: Trends Pharmacol Sci Date: 2015-10 Impact factor: 14.819

4. A Sulfonamide Sialoside Analogue for Targeting Siglec-8 and -F on Immune Cells.

Authors: Corwin M Nycholat; Shiteng Duan; Eva Knuplez; Charli Worth; Mila Elich; Anzhi Yao; Jeremy O'Sullivan; Ryan McBride; Yadong Wei; Steve M Fernandes; Zhou Zhu; Ronald L Schnaar; Bruce S Bochner; James C Paulson
Journal: J Am Chem Soc Date: 2019-08-30 Impact factor: 15.419

5. Glycoengineering of NK Cells with Glycan Ligands of CD22 and Selectins for B-Cell Lymphoma Therapy.

Authors: Senlian Hong; Chenhua Yu; Peng Wang; Yujie Shi; Weiqian Cao; Bo Cheng; Digantkumar G Chapla; Yuanhui Ma; Jie Li; Emily Rodrigues; Yoshiki Narimatsu; John R Yates; Xing Chen; Henrik Clausen; Kelly W Moremen; Matthew Scott Macauley; James C Paulson; Peng Wu
Journal: Angew Chem Int Ed Engl Date: 2020-12-14 Impact factor: 15.336

6. Carbohydrate Recognition Specificity of Trans-sialidase Lectin Domain from Trypanosoma congolense.

Authors: Mario Waespy; Thaddeus T Gbem; Leroy Elenschneider; André-Philippe Jeck; Christopher J Day; Lauren Hartley-Tassell; Nicolai Bovin; Joe Tiralongo; Thomas Haselhorst; Sørge Kelm
Journal: PLoS Negl Trop Dis Date: 2015-10-16

Review 7. Turning-Off Signaling by Siglecs, Selectins, and Galectins: Chemical Inhibition of Glycan-Dependent Interactions in Cancer.

Authors: Alejandro J Cagnoni; Juan M Pérez Sáez; Gabriel A Rabinovich; Karina V Mariño
Journal: Front Oncol Date: 2016-05-13 Impact factor: 6.244

8. Structural characterisation of high affinity Siglec-2 (CD22) ligands in complex with whole Burkitt's lymphoma (BL) Daudi cells by NMR spectroscopy.

Authors: Paul D Madge; Andrea Maggioni; Mauro Pascolutti; Moein Amin; Mario Waespy; Bernadette Bellette; Robin J Thomson; Sørge Kelm; Mark von Itzstein; Thomas Haselhorst
Journal: Sci Rep Date: 2016-11-03 Impact factor: 4.379

9. CD22-Binding Synthetic Sialosides Regulate B Lymphocyte Proliferation Through CD22 Ligand-Dependent and Independent Pathways, and Enhance Antibody Production in Mice.

Authors: Naoko Matsubara; Akihiro Imamura; Tatsuya Yonemizu; Chizuru Akatsu; Hongrui Yang; Akiharu Ueki; Natsuki Watanabe; Hajjaj Abdu-Allah; Nobutaka Numoto; Hiromu Takematsu; Shinobu Kitazume; Thomas F Tedder; Jamey D Marth; Nobutoshi Ito; Hiromune Ando; Hideharu Ishida; Makoto Kiso; Takeshi Tsubata
Journal: Front Immunol Date: 2018-04-19 Impact factor: 7.561

Review 10. Exploration of sialic acid diversity and biology using sialoglycan microarrays.

Authors: Lingquan Deng; Xi Chen; Ajit Varki
Journal: Biopolymers Date: 2013-10 Impact factor: 2.505